Dolutegravir | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dolutegravir
U.S. EXCLUSIVITIES

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Dolutegravir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 25 USDMF, 9 EU WC, 2 KDMF, 12 NDC API, 33 Listed Suppliers, $ API Reference Price

51 API Suppliers
25 USDMF
9 EU WC
2 KDMF
12 NDC API
33 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

38 Intermediates Suppliers

38 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

105 FDF Dossiers, 28 FDA Orange Book, 10 Europe, 7 Canada, 1 Australia, 57 South Africa, 2 Listed Dossiers

105 FDF Dossiers
28 FDA Orange Book
10 Europe
7 Canada
1 Australia
57 South Africa
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 3 DKSH, 2 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 22 Kerry, 12 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 13 Roquette, 2 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 33 Direct Compression, 22 Coating Systems & Additives, 20 Disintegrants & Superdisintegrants, 19 Lubricants & Glidants, 19 Granulation, 18 Thickeners and Stabilizers, 18 Co-Processed Excipients, 16 Controlled & Modified Release, 16 Solubilizers, 13 Chewable & Orodispersible Aids, 12 Parenteral, 11 Taste Masking, 10 Topical, 5 Film Formers & Plasticizers, 3 Coloring Agents, 3 API Stability Enhancers, 2 Rheology Modifiers, 2 Emulsifying Agents, 2 Surfactant & Foaming Agents

70 Fillers, Diluents & Binders
33 Direct Compression
22 Coating Systems & Additives
20 Disintegrants & Superdisintegrants
19 Lubricants & Glidants
19 Granulation
18 Thickeners and Stabilizers
18 Co-Processed Excipients
16 Controlled & Modified Release
16 Solubilizers
13 Chewable & Orodispersible Aids
12 Parenteral
11 Taste Masking
10 Topical
5 Film Formers & Plasticizers
3 Coloring Agents
3 API Stability Enhancers
2 Rheology Modifiers
2 Emulsifying Agents
2 Surfactant & Foaming Agents

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow, 2 STOCK RECAP #PipelineProspector, 125 NEWS #PharmaBuzz

7 DATA COMPILATION #PharmaFlow
2 STOCK RECAP #PipelineProspector
125 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 12 Finished Drug Prices, 32 Annual Reports

3 US Medicaid Prescriptions
12 Finished Drug Prices
32 Annual Reports

MARKET PLACE

8 APIs, 8 FDF Dossiers

8 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 5 US Exclusivities, 1 Health Canada Patents

36 US Patents
5 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 435 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

5 All

01 5VIIV HLTHCARE

filter Product Reset all filters

5 All

01 4ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

02 1DOLUTEGRAVIR SODIUM; LAMIVUDINE

filter Exclusivity Expiration Date Reset all filters

5 All

01 22026-06-15

02 22026-12-15

03 12027-04-05

filter Exclusivity Code Reset all filters

5 All

01 1M-294

02 2NPP

03 2PED

Product Main Page

VIIV HLTHCARE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2026-12-15

Application Number

205551

Product Number

1

Exclusivity Details

01

VIIV HLTHCARE

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Pharmtech & Ingredients

Not Confirmed

VIIV HLTHCARE

United Kingdom

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Exclusivity Code : PED

Exclusivity Expiration Date : 2026-12-15

Application Number : 205551

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VIIV HLTHCARE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DOLUTEGRAVIR SODIUM; LAMIVUDINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-04-05

Application Number

211994

Product Number

1

Exclusivity Details

02

VIIV HLTHCARE

DOLUTEGRAVIR SODIUM; LAMIVUDINE

Pharmtech & Ingredients

Not Confirmed

VIIV HLTHCARE

United Kingdom

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DOLUTEGRAVIR SODIUM; LAMIVUDINE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-04-05

Application Number : 211994

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VIIV HLTHCARE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-06-15

Application Number

215413

Product Number

1

Exclusivity Details

03

VIIV HLTHCARE

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Pharmtech & Ingredients

Not Confirmed

VIIV HLTHCARE

United Kingdom

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-06-15

Application Number : 215413

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VIIV HLTHCARE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-294

Exclusivity Expiration Date

2026-06-15

Application Number

205551

Product Number

1

Exclusivity Details

04

VIIV HLTHCARE

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Pharmtech & Ingredients

Not Confirmed

VIIV HLTHCARE

United Kingdom

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Exclusivity Code : M-294

Exclusivity Expiration Date : 2026-06-15

Application Number : 205551

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VIIV HLTHCARE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2026-12-15

Application Number

215413

Product Number

1

Exclusivity Details

05

VIIV HLTHCARE

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Pharmtech & Ingredients

Not Confirmed

VIIV HLTHCARE

United Kingdom

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Exclusivity Code : PED

Exclusivity Expiration Date : 2026-12-15

Application Number : 215413

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?